These results confirm that overexpression of PLK1 [38–42], BUB1 [80], AURKB [50], HMMR [81], FOXM1 [30–33], MYBL2 [34] and SOX11 [73, 74] are associated with both cancer onset and cancer progression. Here, AURKB is linked to cancer.